Supplemental Figure 2 from Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses

Abstract
Comparison of combination anti-PD1/anti-IL1b and cabozantinib/anti-IL1b treatment.